Effects of calcium and vitamin D co-supplementation on pre-elampsia parameters, metabolic status and biomarkers of oxidative stress in pregnant women at risk for pre-eclampsia
Red color represents old content. It may be empty showing addition in the new version.
Green color represents new content. It may be empty showing deletion in the new version.
Inline
Side by side
Added new contents,
deleted old contents,contents that are not changed.
New table contents
New table contents
Old table contents
Old table contents
Unchanged contents
Unchanged contents
Added new contents, contents that are not changed.
Deleted old contents, contents that are not changed.
Old table contents
Old table contents
Unchanged contents
Unchanged contents
New table contents
New table contents
Unchanged contents
Unchanged contents
Protocol summary
Objective: This study is to determine the effects of vitamin D on metabolic profiles, hs-CRP and biomarkers of oxidative stress in pregnant women at risk for pre-eclampsia. Study design: Randomized double-blind controlled clinical trial. Inclusion and Exclusion Criteria: Pregnant women, primigravida, aged 18-40 year old at 20 weeks' gestation with positive screening tests will be included in this study. Multiparous women as well as those with hypertension, gestational diabetes mellitus (GDM), complete bed rest (CBR), intra uterine fetal death (IUFD), placenta abruption and preterm delivery will be excluded in the study. Population and sample size: 60 pregnant women of eligible and referred to Naghavi Clinic affiliated to Kashan University of Medical Sciences, Kashan, Iran in the study will be selected. Intervention: Patients will be assigned to receive either 50000 IU vitamin D/each 2 weeks and 1000 mg calcium daily (intervention group: n=30) or placebo (control group: n=30). Fasting blood samples will be taken at baseline and after 12-wk intervention to measure metabolic profiles and biomarkers of oxidative stress. Start and End Date of Intervention: 12 weeks (September 7, 2014- December 7, 2014).
empty
Objective: This study is to determine the effects of vitamin D on metabolic profiles, hs-CRP and biomarkers of oxidative stress in pregnant women at risk for pre-eclampsia. Study design: Randomized double-blind controlled clinical trial. Inclusion and Exclusion Criteria: Pregnant women, primigravida, aged 18-40 year old at 20 weeks' gestation with positive screening tests will be included in this study. Multiparous women as well as those with hypertension, gestational diabetes mellitus (GDM), complete bed rest (CBR), intra uterine fetal death (IUFD), placenta abruption and preterm delivery will be excluded in the study. Population and sample size: 60 pregnant women of eligible and referred to Naghavi Clinic affiliated to Kashan University of Medical Sciences, Kashan, Iran in the study will be selected. Intervention: Patients will be assigned to receive either 50000 IU vitamin D/each 2 weeks and 1000 mg calcium daily (intervention group: n=30) or placebo (control group: n=30). Fasting blood samples will be taken at baseline and after 12-wk intervention to measure metabolic profiles and biomarkers of oxidative stress. Start and End Date of Intervention: 12 weeks (September 7, 2014- December 7, 2014).
هدف: این مطالعه تعیین اثرات ویتامین D بر روی پروفایل های متابولیک، پروتئین واکنشگر C و بیومارکرهای استرس اکسیداتیو در زنان باردار در معرض خطر پری اکلامپسی است. طراحی مطالعه: تصادفي، کارآزمایی بالینی کنترل شده دو سوکور. معیار ورود و خروج مطالعه: زنان باردار، با بارداری اول، 40-18 ساله که تک قلو باردار هستند در هفته 20 بارداری با تست های غربالگری مثبت وارد مطالعه خواهند شد. زنان باردار چند قلو و همچنين آن هایی که مبتلا به فشار خون، دیابت بارداری، استراحت مطلق، مرگ جنینی داخل رحمی، جدا شدن جفت و زایمان زودرس از مطالعه خارج خواهند شد. حجم نمونه و جمعیت مورد مطالعه: 60 زن باردار واجد شرایط و ارجاع شده به کلینیک نقوي وابسته به دانشگاه علوم پزشکی كاشان،كاشان، ایران در مطالعه انتخاب خواهند شد. مداخله مورد مطالعه: بیماران برای دریافت 50000 واحد ویتامین D هر دو هفته یک بار و 1000 ميلي گرم كلسيم روزانه (گروه مداخله: 30=n) یا پلاسبو (گروه کنترل: 30=n) تقسیم خواهند شد. نمونه خون ناشتا در ابتدای مطالعه و 12 هفته بعد از مداخله برای تعیین پروفایل های متابولیک و بیومارکرهای استرس اکسیداتیو از بیماران گرفته خواهد شد. زمان مداخله: 12هفته (از 16شهريور 1393 تا 16آذر 1393).
empty
هدف: این مطالعه تعیین اثرات ویتامین D بر روی پروفایل های متابولیک، پروتئین واکنشگر C و بیومارکرهای استرس اکسیداتیو در زنان باردار در معرض خطر پری اکلامپسی است. طراحی مطالعه: تصادفي، کارآزمایی بالینی کنترل شده دو سوکور. معیار ورود و خروج مطالعه: زنان باردار، با بارداری اول، 40-18 ساله که تک قلو باردار هستند در هفته 20 بارداری با تست های غربالگری مثبت وارد مطالعه خواهند شد. زنان باردار چند قلو و همچنين آن هایی که مبتلا به فشار خون، دیابت بارداری، استراحت مطلق، مرگ جنینی داخل رحمی، جدا شدن جفت و زایمان زودرس از مطالعه خارج خواهند شد. حجم نمونه و جمعیت مورد مطالعه: 60 زن باردار واجد شرایط و ارجاع شده به کلینیک نقوي وابسته به دانشگاه علوم پزشکی كاشان،كاشان، ایران در مطالعه انتخاب خواهند شد. مداخله مورد مطالعه: بیماران برای دریافت 50000 واحد ویتامین D هر دو هفته یک بار و 1000 ميلي گرم كلسيم روزانه (گروه مداخله: 30=n) یا پلاسبو (گروه کنترل: 30=n) تقسیم خواهند شد. نمونه خون ناشتا در ابتدای مطالعه و 12 هفته بعد از مداخله برای تعیین پروفایل های متابولیک و بیومارکرهای استرس اکسیداتیو از بیماران گرفته خواهد شد. زمان مداخله: 12هفته (از 16شهريور 1393 تا 16آذر 1393).
empty
This study is to determine the effects of vitamin D on metabolic profiles, hs-CRP and biomarkers of oxidative stress in pregnant women at risk for pre-eclampsia.
This study is to determine the effects of vitamin D on metabolic profiles, hs-CRP and biomarkers of oxidative stress in pregnant women at risk for pre-eclampsia.
empty
این مطالعه تعیین اثرات ویتامین D بر روی پروفایل های متابولیک، پروتئین واکنشگر C و بیومارکرهای استرس اکسیداتیو در زنان باردار در معرض خطر پره اکلامپسی است.
این مطالعه تعیین اثرات ویتامین D بر روی پروفایل های متابولیک، پروتئین واکنشگر C و بیومارکرهای استرس اکسیداتیو در زنان باردار در معرض خطر پره اکلامپسی است.
empty
Study design: Parallel double-blind (both patients and researchers) randomized controlled clinical trial.
Study design: Parallel double-blind (both patients and researchers) randomized controlled clinical trial.
empty
طراحي انجام مطالعه: تصادفي کارآزمایی بالینی دو سوکور (هم بیماران و هم محققان) موازی.
طراحي انجام مطالعه: تصادفي کارآزمایی بالینی دو سوکور (هم بیماران و هم محققان) موازی.
empty
Sixty pregnant women of eligible and referred to Clinic affiliated to Kashan University of Medical Sciences, Kashan, Iran in the study will be selected.
Sixty pregnant women of eligible and referred to Clinic affiliated to Kashan University of Medical Sciences, Kashan, Iran in the study will be selected.
empty
شصت زن باردار واجد شرایط و ارجاع شده به کلینیک وابسته به دانشگاه علوم پزشکی كاشان،كاشان، ایران در مطالعه انتخاب خواهند شد.
شصت زن باردار واجد شرایط و ارجاع شده به کلینیک وابسته به دانشگاه علوم پزشکی كاشان،كاشان، ایران در مطالعه انتخاب خواهند شد.
empty
Inclusion criteria: Primigravida pregnant women; aged 18–40 years old; at risk for pre-eclampsia; lived approximately 20 km or less from the clinic and hospital. Exclusion criteria: Hypertension; renal diseases; gestational diabetes mellitus (GDM); abnormal foetal anomaly scan
Inclusion criteria: Primigravida pregnant women; aged 18–40 years old; at risk for pre-eclampsia; lived approximately 20 km or less from the clinic and hospital. Exclusion criteria: Hypertension; renal diseases; gestational diabetes mellitus (GDM); abnormal foetal anomaly scan
empty
معیار ورود مطالعه: زنان باردار با بارداری اول؛ 40-18 ساله؛ در معرض خطر پره اکلامپسی؛ زندگی تقریبا 20 کیلومتر یا کمتر از کلینیک و بیمارستان. معیار خروج مطالعه: فشار خون؛ بیماری های کلیه؛ دیابت بارداری؛ اسکن آنومالی جنینی غیرطبیعی.
معیار ورود مطالعه: زنان باردار با بارداری اول؛ 40-18 ساله؛ در معرض خطر پره اکلامپسی؛ زندگی تقریبا 20 کیلومتر یا کمتر از کلینیک و بیمارستان. معیار خروج مطالعه: فشار خون؛ بیماری های کلیه؛ دیابت بارداری؛ اسکن آنومالی جنینی غیرطبیعی.
empty
Patients will be assigned to receive either 50000 IU vitamin D/each 2 weeks and 1000 mg calcium daily (intervention group: n=30) or placebo (control group: n=30).
Patients will be assigned to receive either 50000 IU vitamin D/each 2 weeks and 1000 mg calcium daily (intervention group: n=30) or placebo (control group: n=30).
empty
بیماران برای دریافت 50000 واحد ویتامین D هر دو هفته یک بار و 1000 ميلي گرم كلسيم روزانه (گروه مداخله: 30=n) یا پلاسبو (گروه کنترل: 30=n) تقسیم خواهند شد.
بیماران برای دریافت 50000 واحد ویتامین D هر دو هفته یک بار و 1000 ميلي گرم كلسيم روزانه (گروه مداخله: 30=n) یا پلاسبو (گروه کنترل: 30=n) تقسیم خواهند شد.
empty
Pre-eclampsia rate, low birth weight (LBW) (<2500 g), newborn's birth size and preterm delivery (<37 weeks) (primary outcomes) and other metabolic profiles (secondary outcome).
Pre-eclampsia rate, low birth weight (LBW) (<2500 g), newborn's birth size and preterm delivery (<37 weeks) (primary outcomes) and other metabolic profiles (secondary outcome).
empty
پره اکلامپسی، وزن تولد کم (کمتر از 2500 گرم)، سایز تولد نوزادان تازه متولد شده و زایمان زودرس (پیامد اولیه) و سایر پروفایل های متابولیک (پیامدهای ثانویه).
پره اکلامپسی، وزن تولد کم (کمتر از 2500 گرم)، سایز تولد نوزادان تازه متولد شده و زایمان زودرس (پیامد اولیه) و سایر پروفایل های متابولیک (پیامدهای ثانویه).
General information
1
1
1
1
1
1
2
3
23
2014-05-06, 1393/02/16
2014-09-06, 1393/06/15
2014-0509-06 00:00:00
2014-09-07, 1393/06/16
2014-10-06, 1393/07/14
2014-0910-0706 00:00:00
empty
Due to an error, the request for an update in our website has conducted after paper published. However, the revisions were accordance with either the original approved proposal or with coordination with Vice Chancellor of Research at the University.
Due to an error, the request for an update in our website has conducted after paper published. However, the revisions were accordance with either the original approved proposal or with coordination with Vice Chancellor of Research at the University.
empty
بواسطه کم توجهی، درخواست برای بروزرسانی در وب سایت ما بعد از چاپ مقاله انجام شده است. اگرچه، اصلاحات صورت گرفته مطابق با یا پروپوزال اصلی تصویب شده یا با هماهنگی معاونت پژوهشی دانشگاه بود.
بواسطه کم توجهی، درخواست برای بروزرسانی در وب سایت ما بعد از چاپ مقاله انجام شده است. اگرچه، اصلاحات صورت گرفته مطابق با یا پروپوزال اصلی تصویب شده یا با هماهنگی معاونت پژوهشی دانشگاه بود.
Primigravida pregnant women
Aged 18–40 years old
At risk for pre-eclampsia
Lived approximately 20 km or less from the clinic and hospital
Primigravida pregnant women Aged 18–40 years old At risk for pre-eclampsia Lived approximately 20 km or less from the clinic and hospital
زنان باردار با بارداری اول
40-18 ساله
در معرض خطر پره اکلامپسی
زندگی تقریبا 20 کیلومتر یا کمتر از کلینیک و بیمارستان
زنان باردار با بارداری اول 40-18 ساله در معرض خطر پره اکلامپسی زندگی تقریبا 20 کیلومتر یا کمتر از کلینیک و بیمارستان
Randomization and allocation will be concealed from the researchers and participants until the final analyses are completed. Another person at the Clinic who is not involved in the trial and not aware of random sequences will be allocated the numbered bottles of capsules to participants. Supplements and placebo are in the same packaging at the pharmaceutical company. Only the code is written on the packages. Patients and researcher do not know the type of drug and after analyzing the data, packet codes are decoded.
Randomization and allocation will be concealed from the researchers and participants until the final analyses are completed. Another person at the Clinic who is not involved in the trial and not aware of random sequences will be allocated the numbered bottles of capsules to participants. Supplements and placebo are in the same packaging at the pharmaceutical company. Only the code is written on the packages. Patients and researcher do not know the type of drug and after analyzing the data, packet codes are decoded.
empty
تصادفی سازی و تخصیص تصادفی از محققان و شرکت کنندگان در مطالعه تا زمان تکمیل آنالیز آماری پنهان خواهد ماند. فرد دیگری در کلینیک که در این کارآزمایی بالینی نقشی ندارد و از تخصیص تصادفی آگاه نیست، بطری های شماره گذاری شده کپسول ها را به شرکت کنندگان تخصیص خواهد داد. مکمل ها و پلاسبو در شرکت داروسازی در بسته بندی های مشابه قرار می گیرند و بر روی آنها فقط کد گذاشته می شود. بیمار و محقق از نوع مداخله بی خبرند و بعد از آنالیز داده ها، کدهای بسته ها رمز گشایی میشود.
تصادفی سازی و تخصیص تصادفی از محققان و شرکت کنندگان در مطالعه تا زمان تکمیل آنالیز آماری پنهان خواهد ماند. فرد دیگری در کلینیک که در این کارآزمایی بالینی نقشی ندارد و از تخصیص تصادفی آگاه نیست، بطری های شماره گذاری شده کپسول ها را به شرکت کنندگان تخصیص خواهد داد. مکمل ها و پلاسبو در شرکت داروسازی در بسته بندی های مشابه قرار می گیرند و بر روی آنها فقط کد گذاشته می شود. بیمار و محقق از نوع مداخله بی خبرند و بعد از آنالیز داده ها، کدهای بسته ها رمز گشایی میشود.
empty
Patients will be randomly assigned into two groups. A randomization list will be generated from 1 to 60 by a random number generator (https://stattrek.com/statistics/random-number-generator.aspx) and patients will be randomly assigned into each intervention group by their numbers.
Patients will be randomly assigned into two groups. A randomization list will be generated from 1 to 60 by a random number generator (https://stattrek.com/statistics/random-number-generator.aspx) and patients will be randomly assigned into each intervention group by their numbers.
empty
بیماران به طور تصادفی به دو گروه تخصیص داده خواهند شد. یک لیست اعداد تصادفی از 1 تا 60 با استفاده از یک سایت تولید کننده اعداد تصادفی (https://stattrek.com/statistics/random-number-generator.aspx) ایجاد خواهد شد و سپس بیماران با استفاده از اعداد به دو گروه مداخله تخصیص داده خواهند شد.
بیماران به طور تصادفی به دو گروه تخصیص داده خواهند شد. یک لیست اعداد تصادفی از 1 تا 60 با استفاده از یک سایت تولید کننده اعداد تصادفی (https://stattrek.com/statistics/random-number-generator.aspx) ایجاد خواهد شد و سپس بیماران با استفاده از اعداد به دو گروه مداخله تخصیص داده خواهند شد.
empty
empty
Health conditions studied
#1
Pre-eclampcy
Pre-eclampsia
Pre-eclampcyeclampsia
Primary outcomes
#1
Total cholesterol
Pre-eclampsia rate
Total cholesterolPre-eclampsia rate
کلسترول توتال
میزان پره اکلامپسی
کلسترول توتالمیزان پره اکلامپسی
Baseline and 12 weeks after the intervention
After delivery
Baseline and 12 weeks after the interventionAfter delivery
ابتدا و 12 هفته بعد از مداخله
بعد زایمان
ابتدا و 12 هفته بعد از مداخلهزایمان
Enzymatic
Medical record
EnzymaticMedical record
آنزيمي
پرونده پزشکی
آنزيميپرونده پزشکی
#2
LDL-cholesterol
Low birth weight (LBW) (<2500 g)
LDL-cholesterolLow birth weight (LBW) (<2500 g)
کلسترولLDL
کاهش وزن تولد
کلسترولLDLکاهش وزن تولد
Baseline and 12 weeks after the intervention
After delivery
Baseline and 12 weeks after the interventionAfter delivery
قبل از مداخله و 12 هفته بعد از شروع مداخله
بعد زایمان
قبل از مداخله و 12 هفته بعد از شروع مداخلهزایمان
Enzymatic
Scale
EnzymaticScale
آنزیمی
ترازو
آنزیمیترازو
#3
Triglycerides
Newborn's birth size
TriglyceridesNewborn's birth size
تری گلیسرید
سایز تولد نوزادان تازه متولد شده
تری گلیسریدسایز تولد نوزادان تازه متولد شده
Baseline and 12 weeks after the intervention
After delivery
Baseline and 12 weeks after the interventionAfter delivery
قبل از مداخله و 12 هفته بعد از شروع مطالعه
بعد زایمان
قبل از مداخله و 12 هفته بعد از شروع مطالعهزایمان
Enzymatic
Scale and tape
EnzymaticScale and tape
آنزیمی
ترازو و متر
آنزیمیترازو و متر
#4
HDL-cholesterol
Preterm delivery (<37 weeks)
HDL-cholesterolPreterm delivery (<37 weeks)
کلسترولHDL
زایمان زودرس (کمتر از 37 هفته)
کلسترولHDLزایمان زودرس (کمتر از 37 هفته)
Baseline and 12 weeks after the intervention
After delivery
Baseline and 12 weeks after the interventionAfter delivery
قبل از مداخله و 12 هفته بعد از شروع مداخله
بعد زایمان
قبل از مداخله و 12 هفته بعد از شروع مداخلهزایمان
Enzymatic
Medical record
EnzymaticMedical record
آنزیمی
پرونده پزشکی
آنزیمیپرونده پزشکی
#5
Fasting plasma glucose
empty
Fasting plasma glucose
گلوکز پلاسمایی ناشتا
empty
گلوکز پلاسمایی ناشتا
Baseline and 12 weeks after the intervention
empty
Baseline and 12 weeks after the intervention
قبل از مداخله و 12 هفته بعد از شروع مداخله
empty
قبل از مداخله و 12 هفته بعد از شروع مداخله
Enzymatic
empty
Enzymatic
آنزیمی
empty
آنزیمی
#6
Plasma total antioxidant capacity
empty
Plasma total antioxidant capacity
توتال آنتی اکسیدان پلاسما
empty
توتال آنتی اکسیدان پلاسما
Baseline and 12 weeks after the intervention
empty
Baseline and 12 weeks after the intervention
قبل از مداخله و 12 هفته بعد از مداخله
empty
قبل از مداخله و 12 هفته بعد از مداخله
Spectrophotometry
empty
Spectrophotometry
اسپکتروفتومتری
empty
اسپکتروفتومتری
#7
Total glutathione
empty
Total glutathione
گلوتاتیون توتال
empty
گلوتاتیون توتال
Baseline and 12 weeks after the intervention
empty
Baseline and 12 weeks after the intervention
قبل از مداخله و 12 هفته بعد از مداخله
empty
قبل از مداخله و 12 هفته بعد از مداخله
spectrophotometry
empty
spectrophotometry
اسپکتروفتومتری
empty
اسپکتروفتومتری
#8
Serum insulin levels
empty
Serum insulin levels
سطوح انسولین سرم
empty
سطوح انسولین سرم
Baseline and 12 weeks after the intervention
empty
Baseline and 12 weeks after the intervention
قبل از مداخله و 12 هفته بعد از شروع مداخله
empty
قبل از مداخله و 12 هفته بعد از شروع مداخله
Eliza
empty
Eliza
الایزا
empty
الایزا
Secondary outcomes
#1
empty
Insulin
Insulin
empty
انسولین
انسولین
empty
Baseline and End-of-trial
Baseline and End-of-trial
empty
ابتدا و انتهای مطالعه
ابتدا و انتهای مطالعه
empty
Eliza
Eliza
empty
الایزا
الایزا
#2
empty
Nitric oxide
Nitric oxide
empty
نیتریک اکساید
نیتریک اکساید
empty
Baseline and End-of-trial
Baseline and End-of-trial
empty
ابتدا و انتهای مطالعه
ابتدا و انتهای مطالعه
empty
Spectrophotometry
Spectrophotometry
empty
اسپکتروفتومتری
اسپکتروفتومتری
#3
empty
High-sensitivity C-reactive protein
High-sensitivity C-reactive protein
empty
پروتئین واکنشگر C با حساسیت بالا
پروتئین واکنشگر C با حساسیت بالا
empty
Baseline and End-of-trial
Baseline and End-of-trial
empty
ابتدا و انتهای مطالعه
ابتدا و انتهای مطالعه
empty
Eliza
Eliza
empty
الایزا
الایزا
#4
empty
Total antioxidant capacity
Total antioxidant capacity
empty
ظرفیت آنتی اکسیدانی توتال
ظرفیت آنتی اکسیدانی توتال
empty
Baseline and End-of-trial
Baseline and End-of-trial
empty
ابتدا و انتهای مطالعه
ابتدا و انتهای مطالعه
empty
Spectrophotometry
Spectrophotometry
empty
اسپکتروفتومتری
اسپکتروفتومتری
#5
empty
Fasting plasma glucose
Fasting plasma glucose
empty
قند خون ناشتا
قند خون ناشتا
empty
Baseline and End-of-trial
Baseline and End-of-trial
empty
ابتدا و انتهای مطالعه
ابتدا و انتهای مطالعه
empty
Enzymatic
Enzymatic
empty
آنزیمی
آنزیمی
#6
empty
Triglyceride
Triglyceride
empty
تری گلیسرید
تری گلیسرید
empty
Baseline and End-of-trial
Baseline and End-of-trial
empty
ابتدا و انتهای مطالعه
ابتدا و انتهای مطالعه
empty
Enzymatic
Enzymatic
empty
آنزیمی
آنزیمی
#7
empty
Cholesterol
Cholesterol
empty
کلسترول
کلسترول
empty
Baseline and End-of-trial
Baseline and End-of-trial
empty
ابتدا و انتهای مطالعه
ابتدا و انتهای مطالعه
empty
Enzymatic
Enzymatic
empty
آنزیمی
آنزیمی
#8
empty
HDL-cholesterol
HDL-cholesterol
empty
کلسترول HDL
کلسترول HDL
empty
Baseline and End-of-trial
Baseline and End-of-trial
empty
ابتدا و انتهای مطالعه
ابتدا و انتهای مطالعه
empty
Enzymatic
Enzymatic
empty
آنزیمی
آنزیمی
#9
empty
Blood pressures
Blood pressures
empty
فشارخون
فشارخون
empty
Baseline and End-of-trial
Baseline and End-of-trial
empty
ابتدا و انتهای مطالعه
ابتدا و انتهای مطالعه
empty
Manometer
Manometer
empty
مانومتر
مانومتر
Recruitment centers
#1
Name of recruitment center - English: Naghavi Clinic
Name of recruitment center - Persian: کلینیک نقوی
Full name of responsible person - English: Dr Mansooreh Samimi
Full name of responsible person - Persian: دكتر منصوره صميمي
Street address - English: Naghavi Hospital
Street address - Persian: بيمارستان نقوي
City - English: Kashan
City - Persian: كاشان
Province:
Country: Iran (Islamic Republic of)
Postal code:
Phone:
Fax:
Email:
Web page address:
Name of recruitment center - English: Gynecology Clinic
Name of recruitment center - Persian: کلینیک زنان
Full name of responsible person - English: Dr Mansooreh Samimi
Full name of responsible person - Persian: دكتر منصوره صميمي
Street address - English: Shahid Rajaee Street, Kashan
Street address - Persian: کاشان، خیابان شهید رجایی
City - English: Kashan
City - Persian: كاشان
Province: Isfehan
Country: Iran (Islamic Republic of)
Postal code: 8115187159
Phone: +98 31 5546 3378
Fax:
Email: dr_samimi.2007@yahoo.com
Web page address:
Name of recruitment center - English: NaghaviGynecology Clinic Name of recruitment center - Persian: کلینیک نقویزنان Full name of responsible person - English: Dr Mansooreh Samimi Full name of responsible person - Persian: دكتر منصوره صميمي Street address - English: Naghavi HospitalShahid Rajaee Street, Kashan Street address - Persian: بيمارستان نقويکاشان، خیابان شهید رجایی City - English: Kashan City - Persian: كاشان Province: Isfehan Country: Iran (Islamic Republic of) Postal code: 8115187159 Phone: +98 31 5546 3378 Fax: Email: dr_samimi.2007@yahoo.com Web page address:
Sponsors / Funding sources
#1
contact.organization_id:
Name of organization / entity - English: Vice chancellor for research, Kashan University of Medical Sciences
Name of organization / entity - Persian: دانشگاه علوم پزشكي كاشان، معاونت پژوهشی
Full name of responsible person - English: Dr Gholamali Hamidi
Full name of responsible person - Persian: دكتر غلامعلي حميدي
Street address - English: Vice chancellor for research, Ghotbe Ravandi Blvd
Street address - Persian: بلوار قطب راوندي، معاونت پژوهشي
City - English: Kashan
City - Persian: كاشان
Province:
Country: Iran (Islamic Republic of)
Postal code:
Phone:
Fax:
Email:
Web page address:
contact.organization_id:
Name of organization / entity - English: Vice chancellor for research, Kashan University of Medical Sciences
Name of organization / entity - Persian: دانشگاه علوم پزشكي كاشان، معاونت پژوهشی
Full name of responsible person - English: Dr Gholamali Hamidi
Full name of responsible person - Persian: دكتر غلامعلي حميدي
Street address - English: Vice chancellor for research, Ghotbe Ravandi Boulevard
Street address - Persian: بلوار قطب راوندي، معاونت پژوهشي
City - English: Kashan
City - Persian: كاشان
Province: Isfehan
Country: Iran (Islamic Republic of)
Postal code: 8115187159
Phone: +98 31 5554 0021
Fax:
Email: hamidi_g@kaums.ac.ir
Web page address:
contact.organization_id: Name of organization / entity - English: Vice chancellor for research, Kashan University of Medical Sciences Name of organization / entity - Persian: دانشگاه علوم پزشكي كاشان، معاونت پژوهشی Full name of responsible person - English: Dr Gholamali Hamidi Full name of responsible person - Persian: دكتر غلامعلي حميدي Street address - English: Vice chancellor for research, Ghotbe Ravandi BlvdBoulevard Street address - Persian: بلوار قطب راوندي، معاونت پژوهشي City - English: Kashan City - Persian: كاشان Province: Isfehan Country: Iran (Islamic Republic of) Postal code: 8115187159 Phone: +98 31 5554 0021 Fax: Email: hamidi_g@kaums.ac.ir Web page address:
empty
Public
public
empty
Domestic
domestic
empty
Academic
academic
Person responsible for general inquiries
contact.organization_id:
Name of organization / entity - English: Kashan University of Medical Sciences
Name of organization / entity - Persian: دانشگاه علوم پزشكي كاشان
Full name of responsible person - English: Dr Mansooreh Samimi
Full name of responsible person - Persian: دكتر منصوره صميمي
Position - English: Obstetricians
Position - Persian: متخصص زنان و زايمان
Latest degree:
Area of specialty/work: 0
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Beheshti Hospital
Street address - Persian: بيمارستان شهيد بهشتي
City - English: Kashan
City - Persian: كاشان
Province:
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code:
Phone: +98 31 5544 7619
Mobile: +98 913 361 4710
Fax:
Email: samimi_m@kaums.ac.ir; dr_samimi.2007@yahoo.com
Web page address:
contact.organization_id:
Name of organization / entity - English: Kashan University of Medical Sciences
Name of organization / entity - Persian: دانشگاه علوم پزشكي كاشان
Full name of responsible person - English: Dr Mansooreh Samimi
Full name of responsible person - Persian: دكتر منصوره صميمي
Position - English: Obstetricians
Position - Persian: متخصص زنان و زايمان
Latest degree: specialist
Area of specialty/work: 49
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Ghotbe Ravandi Boulevard, Kashan
Street address - Persian: کاشان، بلوار قطب راوندی
City - English: Kashan
City - Persian: كاشان
Province: Isfehan
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code: 8115187159
Phone: +98 31 5544 7619
Mobile: +98 913 361 4710
Fax:
Email: dr_samimi.2007@yahoo.com
Web page address:
contact.organization_id: Name of organization / entity - English: Kashan University of Medical Sciences Name of organization / entity - Persian: دانشگاه علوم پزشكي كاشان Full name of responsible person - English: Dr Mansooreh Samimi Full name of responsible person - Persian: دكتر منصوره صميمي Position - English: Obstetricians Position - Persian: متخصص زنان و زايمان Latest degree: specialist Area of specialty/work: 049 Area of specialty/work title - English: Area of specialty/work title - Persian: Street address - English: Beheshti HospitalGhotbe Ravandi Boulevard, Kashan Street address - Persian: بيمارستان شهيد بهشتيکاشان، بلوار قطب راوندی City - English: Kashan City - Persian: كاشان Province: Isfehan Province - English: Province - Persian: contact.provinces_available: 1 Country: Iran (Islamic Republic of) Postal code: 8115187159 Phone: +98 31 5544 7619 Mobile: +98 913 361 4710 Fax: Email: samimi_m@kaums.ac.ir; dr_samimi.2007@yahoo.com Web page address:
Person responsible for scientific inquiries
contact.organization_id:
Name of organization / entity - English: Kashan University of Medical Sciences
Name of organization / entity - Persian: دانشگاه علوم پزشکی کاشان
Full name of responsible person - English: Dr Mansooreh Samimi
Full name of responsible person - Persian: دكتر منصوره صميمي
Position - English: Obstetricians
Position - Persian: متخصص زنان و زايمان
Latest degree:
Area of specialty/work: 0
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Beheshti Hospital
Street address - Persian: بيمارستان شهيد بهشتي
City - English: Kashan
City - Persian: كاشان
Province:
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code:
Phone: +98 31 5544 7619
Mobile: +98 913 361 4710
Fax:
Email: samimi_m@kaums.ac.ir; dr_samimi.2007@yahoo.com
Web page address:
contact.organization_id:
Name of organization / entity - English: Kashan University of Medical Sciences
Name of organization / entity - Persian: دانشگاه علوم پزشکی کاشان
Full name of responsible person - English: Dr Mansooreh Samimi
Full name of responsible person - Persian: دكتر منصوره صميمي
Position - English: Obstetricians
Position - Persian: متخصص زنان و زايمان
Latest degree: specialist
Area of specialty/work: 49
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Ghotbe Ravandi Boulevard, Kashan
Street address - Persian: کاشان، بلوار قطب راوندی
City - English: Kashan
City - Persian: كاشان
Province: Isfehan
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code: 8115187159
Phone: +98 31 5544 7619
Mobile: +98 913 361 4710
Fax:
Email: dr_samimi.2007@yahoo.com
Web page address:
contact.organization_id: Name of organization / entity - English: Kashan University of Medical Sciences Name of organization / entity - Persian: دانشگاه علوم پزشکی کاشان Full name of responsible person - English: Dr Mansooreh Samimi Full name of responsible person - Persian: دكتر منصوره صميمي Position - English: Obstetricians Position - Persian: متخصص زنان و زايمان Latest degree: specialist Area of specialty/work: 049 Area of specialty/work title - English: Area of specialty/work title - Persian: Street address - English: Beheshti HospitalGhotbe Ravandi Boulevard, Kashan Street address - Persian: بيمارستان شهيد بهشتيکاشان، بلوار قطب راوندی City - English: Kashan City - Persian: كاشان Province: Isfehan Province - English: Province - Persian: contact.provinces_available: 1 Country: Iran (Islamic Republic of) Postal code: 8115187159 Phone: +98 31 5544 7619 Mobile: +98 913 361 4710 Fax: Email: samimi_m@kaums.ac.ir; dr_samimi.2007@yahoo.com Web page address:
Person responsible for updating data
contact.organization_id:
Name of organization / entity - English: Kashan University of Medical Sciences
Name of organization / entity - Persian: دانشگاه علوم پزشكي كاشان
Full name of responsible person - English: Dr Mansooreh Samimi
Full name of responsible person - Persian: دكتر منصوره صميمي
Position - English: Obstetricians
Position - Persian: متخصص زنان و زايمان
Latest degree:
Area of specialty/work: 0
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Beheshti Hospital
Street address - Persian: بيمارستان شهيد بهشتي
City - English: Kashan
City - Persian: كاشان
Province:
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code:
Phone: +98 31 5544 7619
Mobile: +98 913 361 4710
Fax:
Email: samimi_m@kaums.ac.ir; dr_samimi.2007@yahoo.com
Web page address:
contact.organization_id:
Name of organization / entity - English: Kashan University of Medical Sciences
Name of organization / entity - Persian: دانشگاه علوم پزشكي كاشان
Full name of responsible person - English: Dr Mansooreh Samimi
Full name of responsible person - Persian: دكتر منصوره صميمي
Position - English: Obstetricians
Position - Persian: متخصص زنان و زايمان
Latest degree: specialist
Area of specialty/work: 49
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Ghotbe Ravandi Boulevard, Kashan
Street address - Persian: کاشان، بلوار قطب راوندی
City - English: Kashan
City - Persian: كاشان
Province: Isfehan
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code: 8115187159
Phone: +98 31 5544 7619
Mobile: +98 913 361 4710
Fax:
Email: dr_samimi.2007@yahoo.com
Web page address:
contact.organization_id: Name of organization / entity - English: Kashan University of Medical Sciences Name of organization / entity - Persian: دانشگاه علوم پزشكي كاشان Full name of responsible person - English: Dr Mansooreh Samimi Full name of responsible person - Persian: دكتر منصوره صميمي Position - English: Obstetricians Position - Persian: متخصص زنان و زايمان Latest degree: specialist Area of specialty/work: 049 Area of specialty/work title - English: Area of specialty/work title - Persian: Street address - English: Beheshti HospitalGhotbe Ravandi Boulevard, Kashan Street address - Persian: بيمارستان شهيد بهشتيکاشان، بلوار قطب راوندی City - English: Kashan City - Persian: كاشان Province: Isfehan Province - English: Province - Persian: contact.provinces_available: 1 Country: Iran (Islamic Republic of) Postal code: 8115187159 Phone: +98 31 5544 7619 Mobile: +98 913 361 4710 Fax: Email: samimi_m@kaums.ac.ir; dr_samimi.2007@yahoo.com Web page address:
Sharing plan
undecided
undecided
undecided
undecided
undecided
undecided
undecided
undecided
undecided
undecided
undecided
undecided
undecided
undecided
empty
Undecided - It is not yet known if there will be a plan to make this available
Undecided - It is not yet known if there will be a plan to make this available
empty
هنوز تصمیم نگرفتهام - برنامه انتشار آن هنوز مشخص نیست
هنوز تصمیم نگرفتهام - برنامه انتشار آن هنوز مشخص نیست
Protocol summary
Study aim
This study is to determine the effects of vitamin D on metabolic profiles, hs-CRP and biomarkers of oxidative stress in pregnant women at risk for pre-eclampsia.
Design
Study design: Parallel double-blind (both patients and researchers) randomized controlled clinical trial.
Settings and conduct
Sixty pregnant women of eligible and referred to Clinic affiliated to Kashan University of Medical Sciences, Kashan, Iran in the study will be selected.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Primigravida pregnant women; aged 18–40 years old; at risk for pre-eclampsia; lived approximately 20 km or less from the clinic and hospital. Exclusion criteria: Hypertension; renal diseases; gestational diabetes mellitus (GDM); abnormal foetal anomaly scan
Intervention groups
Patients will be assigned to receive either 50000 IU vitamin D/each 2 weeks and 1000 mg calcium daily (intervention group: n=30) or placebo (control group: n=30).
Main outcome variables
Pre-eclampsia rate, low birth weight (LBW) (<2500 g), newborn's birth size and preterm delivery (<37 weeks) (primary outcomes) and other metabolic profiles (secondary outcome).
General information
Reason for update
Due to an error, the request for an update in our website has conducted after paper published. However, the revisions were accordance with either the original approved proposal or with coordination with Vice Chancellor of Research at the University.
Acronym
IRCT registration information
IRCT registration number:IRCT201102135444N3
Registration date:2015-01-31, 1393/11/11
Registration timing:retrospective
Last update:2021-05-27, 1400/03/06
Update count:1
Registration date
2015-01-31, 1393/11/11
Registrant information
Name
Mansoore Samimi
Name of organization / entity
Kashan
Country
Iran (Islamic Republic of)
Phone
+98 36 1446 0180
Email address
samimi_m@kaums.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice chancellor for research, Kashan University of Medical Sciences
Expected recruitment start date
2014-09-06, 1393/06/15
Expected recruitment end date
2014-10-06, 1393/07/14
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effects of calcium and vitamin D co-supplementation on pre-elampsia parameters, metabolic status and biomarkers of oxidative stress in pregnant women at risk for pre-eclampsia
Public title
Effect of supplementation in treatment of pregnancy complications
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Primigravida pregnant women
Aged 18–40 years old
At risk for pre-eclampsia
Lived approximately 20 km or less from the clinic and hospital
Randomization and allocation will be concealed from the researchers and participants until the final analyses are completed. Another person at the Clinic who is not involved in the trial and not aware of random sequences will be allocated the numbered bottles of capsules to participants. Supplements and placebo are in the same packaging at the pharmaceutical company. Only the code is written on the packages. Patients and researcher do not know the type of drug and after analyzing the data, packet codes are decoded.
Blinding (investigator's opinion)
Double blinded
Blinding description
Patients will be randomly assigned into two groups. A randomization list will be generated from 1 to 60 by a random number generator (https://stattrek.com/statistics/random-number-generator.aspx) and patients will be randomly assigned into each intervention group by their numbers.
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics Committee of Kashan University of Medical Sciences
Street address
Ghotbe Ravandi Boulevard, Kashan
City
Kashan
Province
Isfehan
Postal code
8115187159
Approval date
2014-03-31, 1393/01/11
Ethics committee reference number
196/1/5/29/پ
Health conditions studied
1
Description of health condition studied
Pre-eclampsia
ICD-10 code
O94
ICD-10 code description
Sequelae of complication of pregnancy, childbirth and the puerperium
Primary outcomes
1
Description
Pre-eclampsia rate
Timepoint
After delivery
Method of measurement
Medical record
2
Description
Low birth weight (LBW) (<2500 g)
Timepoint
After delivery
Method of measurement
Scale
3
Description
Newborn's birth size
Timepoint
After delivery
Method of measurement
Scale and tape
4
Description
Preterm delivery (<37 weeks)
Timepoint
After delivery
Method of measurement
Medical record
Secondary outcomes
1
Description
Insulin
Timepoint
Baseline and End-of-trial
Method of measurement
Eliza
2
Description
Nitric oxide
Timepoint
Baseline and End-of-trial
Method of measurement
Spectrophotometry
3
Description
High-sensitivity C-reactive protein
Timepoint
Baseline and End-of-trial
Method of measurement
Eliza
4
Description
Total antioxidant capacity
Timepoint
Baseline and End-of-trial
Method of measurement
Spectrophotometry
5
Description
Fasting plasma glucose
Timepoint
Baseline and End-of-trial
Method of measurement
Enzymatic
6
Description
Triglyceride
Timepoint
Baseline and End-of-trial
Method of measurement
Enzymatic
7
Description
Cholesterol
Timepoint
Baseline and End-of-trial
Method of measurement
Enzymatic
8
Description
HDL-cholesterol
Timepoint
Baseline and End-of-trial
Method of measurement
Enzymatic
9
Description
Blood pressures
Timepoint
Baseline and End-of-trial
Method of measurement
Manometer
Intervention groups
1
Description
Intervention group: 50000 IU vitamin D pearl, each two weeks for 12 weeks + 1000 mg calcium tablet, daily for 12 weeks
Category
Treatment - Drugs
2
Description
Control group: Vitamin D Placebo pearl, each two weeks for 12 weeks + Calcium Placebo tablet, daily for 12 weeks
Category
Treatment - Drugs
Recruitment centers
1
Recruitment center
Name of recruitment center
Gynecology Clinic
Full name of responsible person
Dr Mansooreh Samimi
Street address
Shahid Rajaee Street, Kashan
City
Kashan
Province
Isfehan
Postal code
8115187159
Phone
+98 31 5546 3378
Email
dr_samimi.2007@yahoo.com
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Vice chancellor for research, Kashan University of Medical Sciences
Full name of responsible person
Dr Gholamali Hamidi
Street address
Vice chancellor for research, Ghotbe Ravandi Boulevard
City
Kashan
Province
Isfehan
Postal code
8115187159
Phone
+98 31 5554 0021
Email
hamidi_g@kaums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Vice chancellor for research, Kashan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Dr Mansooreh Samimi
Position
Obstetricians
Latest degree
Specialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Ghotbe Ravandi Boulevard, Kashan
City
Kashan
Province
Isfehan
Postal code
8115187159
Phone
+98 31 5544 7619
Fax
Email
dr_samimi.2007@yahoo.com
Web page address
Person responsible for scientific inquiries
Contact
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Dr Mansooreh Samimi
Position
Obstetricians
Latest degree
Specialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Ghotbe Ravandi Boulevard, Kashan
City
Kashan
Province
Isfehan
Postal code
8115187159
Phone
+98 31 5544 7619
Fax
Email
dr_samimi.2007@yahoo.com
Web page address
Person responsible for updating data
Contact
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Dr Mansooreh Samimi
Position
Obstetricians
Latest degree
Specialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Ghotbe Ravandi Boulevard, Kashan
City
Kashan
Province
Isfehan
Postal code
8115187159
Phone
+98 31 5544 7619
Fax
Email
dr_samimi.2007@yahoo.com
Web page address
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available